Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Denicoff

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Computer Assisted Tomography|July 1, 1995
Chemotherapy-induced changes in uterine volume: CT studyP Kolachana, K Cowan, A Denicoff, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
A pilot study of amiodarone with infusional doxorubicin or vinblastine in refractory breast cancerS E Bates, B Meadows, B R Goldspiel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1996
Phase I/II study of 72-hour infusional paclitaxel and doxorubicin with granulocyte colony-stimulating factor in patients with metastatic breast cancerJ S Fisherman, K H Cowan, M Noone, et al.
Blood|October 15, 1995
A phase I study of sequential versus concurrent interleukin-3 and granulocyte-macrophage colony-stimulating factor in advanced breast cancer patients treated with FLAC (5-fluorouracil, leucovorin, doxorubicin, cyclophosphamide) chemotherapyJ A O'Shaughnessy, D J Venzon, M Gossard, et al.
Breast Cancer Research and Treatment|January 5, 2000
Tamoxifen and fenretinide in women with metastatic breast cancerJ Zujewski, L Pai, L Wakefield, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Computer Assisted Tomography|July 1, 1995
Chemotherapy-induced changes in uterine volume: CT studyP Kolachana, K Cowan, A Denicoff, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
A pilot study of amiodarone with infusional doxorubicin or vinblastine in refractory breast cancerS E Bates, B Meadows, B R Goldspiel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1996
Phase I/II study of 72-hour infusional paclitaxel and doxorubicin with granulocyte colony-stimulating factor in patients with metastatic breast cancerJ S Fisherman, K H Cowan, M Noone, et al.
Blood|October 15, 1995
A phase I study of sequential versus concurrent interleukin-3 and granulocyte-macrophage colony-stimulating factor in advanced breast cancer patients treated with FLAC (5-fluorouracil, leucovorin, doxorubicin, cyclophosphamide) chemotherapyJ A O'Shaughnessy, D J Venzon, M Gossard, et al.
Breast Cancer Research and Treatment|January 5, 2000
Tamoxifen and fenretinide in women with metastatic breast cancerJ Zujewski, L Pai, L Wakefield, et al.
Pageof 1